X0306 4 2021-12-15 1 0001831097 agilon health, inc. AGL 0001856025 Danieley Joan C/O AGILON HEALTH, INC. 1 WORLD TRADE CENTER, SUITE 2000 LONG BEACH CA 90831 0 1 0 0 Chief Administrative Officer Common Stock 2021-12-15 4 M 0 25000 4.45 A 30434 D Common Stock 2021-12-15 4 S 0 15321 22.58 D 15113 D Common Stock 2021-12-15 4 S 0 9679 23.29 D 5434 D Common Stock 2021-12-16 4 M 0 3519 4.45 A 8953 D Common Stock 2021-12-16 4 S 0 3519 23.14 D 5434 D Options (Rights to Buy) 4.45 2021-12-15 4 M 0 25000 0.00 D 2030-01-31 Common Stock 25000 75000 D Options (Rights to Buy) 4.45 2021-12-16 4 M 0 3519 0.00 D 2030-01-31 Common Stock 3519 71481 D Includes restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.92 to $22.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.96 to $23.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.03 to $23.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on January 31, 2020 and are scheduled to vest in four equal installments on each anniversary of August 13, 2019, subject to continued employment. /s/ Lyn Amor Macaraeg, as Attorney-in-Fact 2021-12-17